SE0102639D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0102639D0 SE0102639D0 SE0102639A SE0102639A SE0102639D0 SE 0102639 D0 SE0102639 D0 SE 0102639D0 SE 0102639 A SE0102639 A SE 0102639A SE 0102639 A SE0102639 A SE 0102639A SE 0102639 D0 SE0102639 D0 SE 0102639D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- novel compounds
- compounds
- prophylaxis
- pain
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102639A SE0102639D0 (sv) | 2001-07-31 | 2001-07-31 | Novel compounds |
| JP2003517023A JP2004538313A (ja) | 2001-07-31 | 2002-07-26 | ヘテロアリールへテロアルキルアミン誘導体および一酸化窒素シンターゼの阻害剤としてのそれらの使用 |
| PCT/SE2002/001415 WO2003011831A1 (en) | 2001-07-31 | 2002-07-26 | Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| US10/484,960 US7119109B2 (en) | 2001-07-31 | 2002-07-26 | Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| EP02751942A EP1421067A1 (en) | 2001-07-31 | 2002-07-26 | Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102639A SE0102639D0 (sv) | 2001-07-31 | 2001-07-31 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0102639D0 true SE0102639D0 (sv) | 2001-07-31 |
Family
ID=20284964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0102639A SE0102639D0 (sv) | 2001-07-31 | 2001-07-31 | Novel compounds |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7119109B2 (enExample) |
| EP (1) | EP1421067A1 (enExample) |
| JP (1) | JP2004538313A (enExample) |
| SE (1) | SE0102639D0 (enExample) |
| WO (1) | WO2003011831A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7417064B2 (en) | 2002-11-05 | 2008-08-26 | Eli Lilly And Company | 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| US20090023772A1 (en) * | 2004-08-26 | 2009-01-22 | Eriksen Birgitte L | Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| EP1757290A1 (en) | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| US8183266B2 (en) * | 2007-06-04 | 2012-05-22 | Intra-Cellular Therapies, Inc. | Methods |
| EP2431035A1 (en) | 2010-09-16 | 2012-03-21 | Æterna Zentaris GmbH | Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors |
| GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3535328A (en) * | 1967-09-01 | 1970-10-20 | Exxon Research Engineering Co | Certain substituted aminothioethoxy pyridines |
| JPS5144934B1 (enExample) * | 1969-12-09 | 1976-12-01 | ||
| GB2060622B (en) * | 1979-09-14 | 1983-05-25 | Wyeth John & Brother Ltd | 3-aryl-3-aryloxyalkylamines |
| DE3138550A1 (de) * | 1981-09-28 | 1983-04-07 | Boehringer Ingelheim KG, 6507 Ingelheim | Substituierte 2-phenyl-2-(pyridyloxy)-ethylamine und isostere verbindungen, verfahren zu ihrer herstellung und verwendung |
| DK258389D0 (da) | 1989-05-26 | 1989-05-26 | Ferrosan As | Aryloxyphenylpropylaminer, deres fremstilling og anvendelse |
| EP0571685A1 (en) * | 1992-05-27 | 1993-12-01 | Novo Nordisk A/S | Aryloxyheteroarylpropylamines, their preparation and use |
| ES2169102T3 (es) | 1994-10-14 | 2002-07-01 | Merck Patent Gmbh | (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central. |
| SE0102641D0 (sv) * | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
-
2001
- 2001-07-31 SE SE0102639A patent/SE0102639D0/xx unknown
-
2002
- 2002-07-26 US US10/484,960 patent/US7119109B2/en not_active Expired - Fee Related
- 2002-07-26 EP EP02751942A patent/EP1421067A1/en not_active Withdrawn
- 2002-07-26 JP JP2003517023A patent/JP2004538313A/ja active Pending
- 2002-07-26 WO PCT/SE2002/001415 patent/WO2003011831A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US7119109B2 (en) | 2006-10-10 |
| WO2003011831A1 (en) | 2003-02-13 |
| EP1421067A1 (en) | 2004-05-26 |
| JP2004538313A (ja) | 2004-12-24 |
| US20040220234A1 (en) | 2004-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03010142A (es) | Nuevos derivados de arilheteroalquilamina. | |
| NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| SE9803518D0 (sv) | Novel compounds | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| SE0302324D0 (sv) | Novel compounds | |
| ATE331711T1 (de) | Entzündungshemmende 3-arylthio-3- thiazolylalkylamine | |
| ATE301654T1 (de) | Naphthyridinderivate | |
| SE0302323D0 (sv) | Novel compounds | |
| SE9701304D0 (sv) | Compounds | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| SE0302756D0 (sv) | Novel Compounds | |
| AU1182702A (en) | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | |
| SE9803773D0 (sv) | Compounds | |
| SE0102641D0 (sv) | Novel compounds | |
| GB0004152D0 (en) | Novel compounds | |
| SE0103325D0 (sv) | Novel compounds | |
| SE0102640D0 (sv) | Novel compounds | |
| SE0202280D0 (sv) | Novel compounds | |
| SE0300907D0 (sv) | Novel compounds | |
| NO20042729L (no) | Heksasykliske forbindelser | |
| SE9901530D0 (sv) | Novel compounds | |
| SE0202279D0 (sv) | Novel comppounds | |
| SE0300906D0 (sv) | Novel compounds | |
| SE9901901D0 (sv) | Compounds | |
| CO5660084A1 (es) | Nuevos derivados de fenilheteroalquilamina, proceso para su prepraracion, composiciones farmaceuticas que comprenden dichos derivados novedosos y su uso en terapia |